Am J Physiol Cell Physiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 283: C1715-C1721, 2002; doi:10.1152/ajpcell.00143.2002
0363-6143/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, C.
Right arrow Articles by Asano, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, C.
Right arrow Articles by Asano, Y.
Vol. 283, Issue 6, C1715-C1721, December 2002

Modulation of the erythropoietin-induced proliferative pathway by cAMP in vascular smooth muscle cells

Chiharu Ito1, Eiji Kusano1, Yusuke Furukawa2, Hisashi Yamamoto1, Shin-Ichi Takeda1, Tetsu Akimoto1, Osamu Iimura1, Yasuhiro Ando1, and Yasushi Asano1

1 Divisions of Nephrology and 2 Molecular Hematopoiesis, Department of Internal Medicine, Jichi Medical School, Tochigi 329-0498, Japan

We previously reported that erythropoietin (Epo) has a mitogenic effect on rat vascular smooth muscle cells (VSMC) and that activation of the mitogen-activated protein kinase (MAPK) cascade is an important mediator for Epo-induced mitogenesis. An increase in intracellular cAMP has an antiproliferative effect on VSMC. We therefore hypothesized that cAMP effectors inhibit Epo-induced MAPK activation in rat VSMC. When we exposed VSMC to recombinant human Epo (rHuEpo), DNA synthesis was increased. Forskolin (Fsk) or cilostazol (Cil) decreased the DNA synthesis stimulated by rHuEpo. Coincubation with Rp-cAMPS triethylamine canceled the suppression of DNA synthesis and MAPK activity by Fsk. Both rHuEpo and phorbol 12-myristate 13-acetate upregulated phosphorylations of MEK and MAPK. Pretreatment with Fsk inhibited these phosphorylations. Protein kinase C inhibitors also suppressed MEK and MAPK phosphorylations. Moreover, Fsk induced phosphorylation of Raf-1 at serine-259. These results indicated that cAMP inhibited Epo-induced MAPK activation and that this suppression might be regulated upstream or at Raf-1. The results also suggested that these agents, which could accumulate cAMP, might be protective for Epo-stimulated direct action.

mitogen-activated protein kinase; MEK; Raf-1; protein kinase C


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Erlinge
Extracellular ATP: a central player in the regulation of vascular smooth muscle phenotype. Focus on "Dual role of PKA in phenotype modulation of vascular smooth muscle cells by extracellular ATP"
Am J Physiol Cell Physiol, August 1, 2004; 287(2): C260 - C262.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Hasegawa, K. F. Wagner, D. Karp, D. Li, J. Shibata, M. Heringlake, L. Bahlmann, R. Depping, J. Fandrey, P. Schmucker, et al.
Altered Pulmonary Vascular Reactivity in Mice with Excessive Erythrocytosis
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 829 - 835.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online